Report Content
Chapter 1 Methodology & Scope
1.1 Market scope & definitions
1.2 Research design
1.2.1 Research approach
1.2.2 Data collection methods
1.3 Base estimates & calculations
1.3.1 Base year calculation
1.3.2 Key trends for market estimation
1.4 Forecast model
1.5 Primary research and validation
1.5.1 Primary sources
1.5.2 Data mining sources
Chapter 2 Executive Summary
2.1 Industry 3600 synopsis
Chapter 3 Industry Insights
3.1 Industry ecosystem analysis
3.2 Industry impact forces
3.2.1 Growth drivers
3.2.1.1 Growth in molecular diagnostic tests
3.2.1.2 Increasing demand for timely diagnosis of chronic diseases
3.2.1.3 Rapid adoption of point of care testing technologies
3.2.1.4 Advances in enzyme production technology
3.2.2 Industry pitfalls & challenges
3.2.2.1 Stringent regulatory requirements
3.2.2.2 Concerns related to product quality and safety
3.3 Growth potential analysis
3.4 Future market trends
3.5 Regulatory landscape
3.6 Porter's analysis
3.7 PESTEL analysis
Chapter 4 Competitive Landscape, 2023
4.1 Introduction
4.2 Company market share analysis
4.3 Company matrix analysis
4.4 Competitive positioning matrix
4.5 Strategy dashboard
Chapter 5 Market Estimates and Forecast, By Product, 2021 – 2032 ($ Mn)
5.1 Key trends
5.2 Polymerases and nucleases
5.3 Proteases
5.4 Oxidases
5.5 Carbohydrase
5.6 Other products
Chapter 6 Market Estimates and Forecast, By Application, 2021 – 2032 ($ Mn)
6.1 Key trends
6.2 Molecular diagnostics
6.3 Immunoassay
6.4 Clinical chemistry
6.4.1 Blood glucose monitoring
6.4.2 POC testing
6.4.3 Other clinical chemistry tests
6.5 Other applications
Chapter 7 Market Estimates and Forecast, By Region, 2021 – 2032 ($ Mn)
7.1 Key trends
7.2 North America
7.2.1 U.S.
7.2.2 Canada
7.3 Europe
7.3.1 Germany
7.3.2 UK
7.3.3 France
7.3.4 Spain
7.3.5 Italy
7.3.6 Netherlands
7.3.7 Rest of Europe
7.4 Asia Pacific
7.4.1 China
7.4.2 Japan
7.4.3 India
7.4.4 Australia
7.4.5 South Korea
7.4.6 Rest of Asia Pacific
7.5 Latin America
7.5.1 Brazil
7.5.2 Mexico
7.5.3 Rest of Latin America
7.6 Middle East and Africa
7.6.1 South Africa
7.6.2 Saudi Arabia
7.6.3 UAE
7.6.4 Rest of Middle East and Africa
Chapter 8 Company Profiles
8.1 Agilent Technologies, Inc.
8.2 Amano Enzymes Inc.
8.3 American Laboratories, Inc.
8.4 BBI Solutions
8.5 Biocatalysts Ltd. (BRAIN Biotech Group)
8.6 Bio-Rad Laboratories, Inc.
8.7 Codexis, Inc.
8.8 F. Hoffmann-La Roche Ltd.
8.9 Merck KGaA
8.10 New England Biolabs
8.11 Novozymes A/S
8.12 QIAGEN
8.13 SEKISUI Diagnostics
8.14 Takara Bio Inc.
8.15 Thermo Fisher Scientific Inc.
